CA
MBOT icon

Cornerstone Advisory’s Microbot Medical MBOT Stock Holding History

Cornerstone Advisory’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5K Hold
10,000
– – ﹤0.01% 278
2026
Q1 		$24.1K Hold
10,000
– – ﹤0.01% 261
2025
Q4 		$20K Hold
10,000
– – ﹤0.01% 248
2025
Q3 		$30.5K Buy
+10,000
New +$31.2K ﹤0.01% 244

Other funds holding MBOT

AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
LCM
Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
API
Asset Planning Inc Cypress, California $154M AUM 25.18% 1-Year Est. Return
GP
Guardian Partners Toronto, Canada $1.11B AUM 38.73% 1-Year Est. Return

Cornerstone Advisory's MBOT Position: Q2 2026 in Review

Cornerstone Advisory held its Microbot Medical (MBOT) position steady in Q2 2026 at 10,000 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #278.

Cornerstone Advisory first reported a position in MBOT in Q3 2025 and has held it in 4 quarters since. The position peaked at $30.5K in Q3 2025. 19 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Cornerstone Advisory held 10,000 shares of Microbot Medical worth $19.5K as of Q2 2026.
  • Cornerstone Advisory left its Microbot Medical share count unchanged in Q2 2026.
  • Microbot Medical made up ﹤0.01% of Cornerstone Advisory's portfolio in Q2 2026, its #278 holding.
  • Cornerstone Advisory first reported a position in Microbot Medical in Q3 2025 and has held it in 4 quarters since.
  • Cornerstone Advisory's Microbot Medical position peaked at $30.5K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Cornerstone Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.